Abstract:Background There is increasing evidence revealing sex differences in the manifestations of axial spondyloarthritis (axSpA). However, the results in this regard are heterogeneous and studies that analyze the influence of sex on cardiovascular (CV) risk are lacking. Objectives To assess the CV profile of male and female axSpA patients and to determine the potential impact of sex-specific disease-related characteristics on atherosclerosis in these patients. Methods This is a cross-sectional study of the AtheSpAin cohort, a Spanish multicenter cohort to study atherosclerosis in axSpA. Data on clinical and subclinical atherosclerosis, as well as CV and disease-related characteristics were collected in 912 patients. Results 611 men and 301 women were recruited for this study. Smoking habit (p=0.033), hypertension (p=0.009), and dyslipidemia (p=0.015) were less prevalent in women, who also showed less severe atherosclerosis measured by the presence of carotid plaques (p=0.001), carotid intima-media thickness (IMT) values (p<0.001), and CV events (p=0.008). After adjustment for traditional CV risk factors only the results regarding carotid IMT remained statistically significant. Regarding disease-related features, radiographic axSpA (r-axSpA) was more common in men (p<0.001). Women with axSpA showed a shorter disease duration (p<0.001), a lower prevalence of psoriasis (p=0.008), higher ESR levels at diagnosis (p=0.038) and more active disease measured by ASDAS (p=0.012) and BASDAI (p<0.001). However, they had less structural damage (mSASSS, p<0.001) and mobility limitation (BASMI, p=0.033). These differences that remained statistically significant after adjustment for r-axSpA/nr-axSpA, disease duration or smoking. Remarkably, many of these sex-related differentiating characteristics were associated with subclinical atherosclerosis (table 1). To clarify if this finding could lead to sex differences in the atherosclerotic burden, we compared the prevalence of carotid plaques in men and women with the same level of CV risk stratified according to the SCORE. Within the category of low-moderate SCORE, men showed more severe atherosclerosis than women (p=0.050), which could be related to a longer disease duration (p=0.004), higher mSASSS (p=0.001) and BASMI (p=0.071) values. However, in patients with high-very high SCORE, carotid plaques were more commonly observed in the female group (p=0.025), which was characterized by a higher inflammatory burden (ESR at diagnosis, p=0.007) and worse BASFI (p=0.011) compared with men, with no differences regarding disease duration, mSASSS or BASMI. Conclusion Although the burden of traditional CV risk factors leading to more severe atherosclerotic disease is greater in men with axSpA, potential sex-related proatherogenic features of axSpA also appear to have an impact on CV risk. This may be especially applicable to women at high CV risk, who have a greater inflammatory response, worse functional impairment, and more severe subclinical atherosclerosis than males, suggesting a closer interaction between atherosclerosis and disease burden in women with axSpA. Reference [1]Stovall R, et al. Sexual dimorphism in the prevalence, manifestation and outcomes of axial spondyloarthritis. Nat Rev Rheumatol. 2022 Nov;18(11):657-669 Acknowledgements FG and JR-G are beneficiaries of a grant funded by ‘Instituto de Salud Carlos III’ (ISCIII) (PI20/00059) Disclosure of Interests None Declared.

Sex-specific disparities in disease activity scores among patients with axial spondyloarthritis and their implications for evaluating the response to tumor necrosis factor alpha inhibitor therapy

Sex differences in patient-reported outcomes and the association with clinical factors in axial spondyloarthritis patients treated with tumour necrosis factor inhibitors

Efficacy and safety of TNF-α inhibitors for active ankylosing spondylitis patients: Multiple treatment comparisons in a network meta-analysis

Molecular Profiling of Axial Spondyloarthritis Patients Reveals an Association between Innate and Adaptive Cell Populations and Therapeutic Response to Tumor Necrosis Factor Inhibitors

Sex differential impact of comorbidities in spondyloarthritis: data from COMOSPA study

POS0363 SEX DIFFERENCES IN CARDIOVASCULAR AND DISEASE-RELATED FEATURES IN AXIAL SPONDYLOARTHRITIS. A MULTICENTERSTUDYOF 912 PATIENTS

Single-Cell Analysis of Patients with Axial Spondyloarthritis after Anti-TNF Treatment: Experimental Data and Review of the Literature

Are There Sex-Related Differences in the Effectiveness of Janus Kinase Inhibitors in Rheumatoid Arthritis Patients?

Ankylosing Spondylitis versus Nonradiographic Axial Spondyloarthritis: Comparison of Tumor Necrosis Factor Inhibitor Effectiveness and Effect of HLA-B27 Status. An Observational Cohort Study from the Nationwide DANBIO Registry

Association of Therapies for Axial Spondyloarthritis on the Risk of Hip and Spine Fractures

Single-Cell Analysis of Patients with Axial Spondyloarthritis After Anti-TNFα Treatment: Experimental Data and Review of the Literature

Gender Differences in Axial Spondyloarthritis: Women Are Not So Lucky

Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey

Gender differences in clinical features and quality of life of patients with axial spondyloarthritis and psoriatic arthritis

Heterogeneity of axial spondyloarthritis: genetics, sex and structural damage matter

AB0662 Indirect Comparison of TNF Inhibitors for Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis: Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials

The Ankylosing Spondylitis Disease Activity Score Is A Highly Discriminatory Measure Of Disease Activity And Efficacy Following Tumour Necrosis Factor-Alpha Inhibitor Therapies In Ankylosing Spondylitis And Undifferentiated Spondyloarthropathies In China

Comparative Efficacy of Advanced Therapies in the Treatment of Radiographic Axial Spondyloarthritis or Ankylosing Spondylitis as Evaluated by the ASDAS Low Disease Activity Criteria

Impact of Tumor Necrosis Factor Α Inhibitors on MRI Inflammation in Axial Spondyloarthritis Assessed by Spondyloarthritis Research Consortium Canada Score: A Meta-Analysis.

Influence of tumor necrosis factor α inhibitors on testicular function and semen in spondyloarthritis patients

How to Monitor Disease Activity of Axial Spondyloarthritis in Clinical Practice